Association between the 120‐bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: Genetic and molecular analyses
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Abnormalities of the dopamine neurotransmission have been hypothesized to play an important role in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Promoter variants of the dopamine D4 receptor gene (DRD4) have attracted particular interest due to their possible role in regulation of gene transcription. Here we describe the haplotype analysis of the 120 base pair duplication (120‐bp dup) and three SNPs (−616C/G, −615A/G, −521C/T) in the 5′ region of the DRD4 gene among children with ADHD. We observed a trend (χ 2 = 14.905, df = 9, P = 0.093) in the four‐locus haplotype distribution between ADHD probands (N = 173) and controls (N = 284). The homozygote genotype of the 1‐repeat form of the 120‐bp dup (1–1) had a significantly higher frequency among ADHD children than in controls (8.1% vs. 3.2%, χ 2 = 5.526, df = 1, P = 0.019, Odds Ratio = 2.71). In addition, a novel, 4‐repeat allele was identified among ADHD patients. This particular allele has been cloned to the luciferase expression vector and its transcriptional activity has been compared to the 1‐ and 2‐repeat allele. The number of repeats of the 120‐bp dup was found to have an effect on transcriptional activity in both neuroblastoma and retinoblastoma cell lines in a dose‐dependent manner (1‐repeat > 2‐repeat > 4‐repeat). These results suggest that the 1‐repeat form of the 120‐bp dup might be a risk factor of ADHD, especially in the homozygous form and/or in the context of certain haplotypes. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conners, C. K., Sitarenios, G., Parker, J. D. A., & Epstein, J. N. (1998) · Journal of Abnormal Child Psychology · doi:10.1023/a:1022602400621 · Cited by 1,772
McCracken, J. T., Smalley, S. L., McGough, J. J., Crawford, L., Del'Homme, M., Cantor, R. M., Liu, A., & Nelson, S. F. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000770 · Cited by 189 · cited 4×
“A few studies indicated the 2-repeat form as a risk factor for ADHD [McCracken et al., 2000;Kustanovich et al., 2004],while others did not [Todd et al.”
BackgroundResultInfluential
Cited by
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis
Wu, J., Xiao, H., Sun, H., Zou, L., & Zhu, L.-Q. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8278-5 · Cited by 274
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood
Nemoda, Z., Szekely, A., & Sasvari-Szekely, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.002 · Cited by 78
Self-citationQuantitative and Molecular Genetics of ADHD
Asherson, P., & Gurling, H. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_155 · Cited by 43
“However, meta-analysis of the data (Barr et al. 2001; Kereszturi et al. 2007; Lowe et al. 2004b; Payton et al. 2001) suggests that this polymorphism may have a role in ADHD (P 1⁄4 0.”
BackgroundGrünblatt, E., Nemoda, Z., Werling, A. M., Roth, A., Angyal, N., Tarnok, Z., Thomsen, H., Peters, T., Hinney, A., Hebebrand, J., et al. (2019) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32695 · Cited by 32
“Hungary and Würzburg, Germany, which were described in detail previously (Kereszturi et al., 2007; Walitza et al., 2005).”
BackgroundSelf-citation
Metadata
- Authors
- Kereszturi, E., Kiraly, O., Csapo, Z., Tarnok, Z., Gadoros, J., Sasvari‐Szekely, M., & Nemoda, Z.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2006-12-14
- Volume
- 144B
- Issue
- 2
- Pages
- 231-236
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2029256497
- Cited by
- 53
- References
- 2
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.